Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Date of first FDA approval: August 1, 2014 Indications Jardiance is FDA-approved for: Type 2 diabetes, heart failure and chronic kidney disease Price of Jardiance: $570.48 for a one-month supply Why it did so well: Jardiance belongs to a class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors, inhibiting the SGLT2 protein in the kidneys to lead to the excretion of excess glucose through the urine
This compound has generated significant research interest for its metabolic effects, including appetite modulation, blood sugar regulation, and lipid metabolism support
Why Are Tesamorelin Searches Up 49% in Six Months
Retrieved 8 November 2013
US$ 23.48
US$ 28.40
US$ 21.35
US$ 23.29
US$ 20.05
US$ 21.19
US$ 21.71
